Literature DB >> 15531769

C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity.

Terry W Du Clos1, Carolyn Mold.   

Abstract

C-reactive protein (CRP) is an acute-phase serum protein and a member of the pentraxin protein family. Its host defense functions predate the adaptive immune system by millions of years. Our current understanding of CRP interactions with complement and with Fcgamma receptors (FcgammaR) have led to an increased appreciation of the regulatory role of CRP in inflammation and autoimmunity. This review outlines the role of CRP in infection, inflammation, and autoimmune disease. We provide a description of recent studies, which suggest that CRP acts through FcgammaR to reduce inflammation and protect from certain autoimmune diseases. A general description of the proposed function of CRP is provided as a framework for future investigation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15531769     DOI: 10.1385/IR:30:3:261

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  111 in total

Review 1.  Immune inhibitory receptors.

Authors:  J V Ravetch; L L Lanier
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

2.  Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis.

Authors:  D Bharadwaj; C Mold; E Markham; T W Du Clos
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

3.  Strong acceleration of murine lupus by injection of the SmD1(83-119) peptide.

Authors:  G Riemekasten; A Kawald; C Weiss; A Meine; J Marell; R Klein; B Hocher; C Meisel; G Hausdorf; R Manz; T Kamradt; G R Burmester; F Hiepe
Journal:  Arthritis Rheum       Date:  2001-10

4.  C-reactive protein mediates protection from lipopolysaccharide through interactions with Fc gamma R.

Authors:  Carolyn Mold; Wilfredo Rodriguez; Bojana Rodic-Polic; Terry W Du Clos
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

5.  Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins).

Authors:  A P Osmand; B Friedenson; H Gewurz; R H Painter; T Hofmann; E Shelton
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

6.  C-reactive protein frequently localizes in the kidney in glomerular diseases.

Authors:  C Nakahara; K Kanemoto; N Saito; Y Oyake; T Kamoda; M Nagata; A Matsui
Journal:  Clin Nephrol       Date:  2001-05       Impact factor: 0.975

7.  Localisation of C reactive protein in infarcted tissue sites of multiple organs during sepsis.

Authors:  A Baidoshvili; R Nijmeijer; W K Lagrand; C E Hack; H W M Niessen
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

8.  Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice.

Authors:  T Takai; M Ono; M Hikida; H Ohmori; J V Ravetch
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

9.  Secretion of C-reactive protein becomes more efficient during the course of the acute phase response.

Authors:  S S Macintyre; I Kushner; D Samols
Journal:  J Biol Chem       Date:  1985-04-10       Impact factor: 5.157

10.  Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.

Authors:  C Gérard; C Bruyns; A Marchant; D Abramowicz; P Vandenabeele; A Delvaux; W Fiers; M Goldman; T Velu
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  107 in total

1.  Membrane curvature recognition by C-reactive protein using lipoprotein mimics.

Authors:  Min S Wang; Reid E Messersmith; Scott M Reed
Journal:  Soft Matter       Date:  2012-08-14       Impact factor: 3.679

2.  High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome.

Authors:  Anna Wasilewska; Walentyna Zoch-Zwierz; Jolanta Tobolczyk; Edyta Tenderenda
Journal:  Pediatr Nephrol       Date:  2006-11-18       Impact factor: 3.714

Review 3.  Biomarkers for risk prediction in acute decompensated heart failure.

Authors:  A Rogier van der Velde; Wouter C Meijers; Rudolf A de Boer
Journal:  Curr Heart Fail Rep       Date:  2014-09

4.  A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancer.

Authors:  Ting Zhou; Shaodong Hong; Zhihuang Hu; Xue Hou; Yan Huang; Hongyun Zhao; Wenhua Liang; Yuanyuan Zhao; Wenfeng Fang; Xuan Wu; Tao Qin; Li Zhang
Journal:  Tumour Biol       Date:  2014-09-26

5.  Glasgow Prognostic Score is superior to ECOG PS as a prognostic factor in patients with gastric cancer with peritoneal seeding.

Authors:  Shu-Qiang Yuan; Run-Cong Nie; Yong-Ming Chen; Hai-Bo Qiu; Xiao-Ping Li; Xiao-Jiang Chen; Li-Pu Xu; Li-Fang Yang; Xiao-Wei Sun; Yuan-Fang Li; Zhi-Wei Zhou; Shi Chen; Ying-Bo Chen
Journal:  Oncol Lett       Date:  2018-01-19       Impact factor: 2.967

6.  Serial CRP levels following oesophagectomy: a marker for anastomotic dehiscence.

Authors:  Peter McAnena; Colm Neary; Conor Doyle; Michael J Kerin; Oliver J McAnena; Chris Collins
Journal:  Ir J Med Sci       Date:  2019-08-01       Impact factor: 1.568

Review 7.  Novel risk factors for cardiovascular disease in rheumatoid arthritis.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Ruben-Dario Mantilla; Ricardo Pineda-Tamayo; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

8.  Association of a single nucleotide polymorphism in the C-reactive protein gene (-286) with susceptibility to Plasmodium falciparum malaria.

Authors:  Hayder A Giha; Amre Nasr; Mattias Ekström; Elisabeth Israelsson; Gishanthi Arambepola; David Arnot; Thor G Theander; Marita Troye-Blomberg; Klavs Berzins; Per Tornvall; Gehad ElGhazali
Journal:  Mol Med       Date:  2009-11-17       Impact factor: 6.354

Review 9.  Potential role for mucosally active vaccines against pneumococcal pneumonia.

Authors:  Kondwani C Jambo; Enoch Sepako; Robert S Heyderman; Stephen B Gordon
Journal:  Trends Microbiol       Date:  2009-12-22       Impact factor: 17.079

10.  Serum C-Reactive Protein (CRP), Target for Therapy or Trouble?

Authors:  Virginia B Kraus; Joanne M Jordan
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.